Novo Integrated Sciences Debt to Equity Ratio 2012-2024 | NVOS

Current and historical debt to equity ratio values for Novo Integrated Sciences (NVOS) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Novo Integrated Sciences debt/equity for the three months ending February 29, 2024 was 0.00.
Novo Integrated Sciences Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-02-29 $0.01B $0.02B 0.60
2023-11-30 $0.01B $0.02B 0.60
2023-08-31 $0.01B $0.02B 0.45
2023-05-31 $0.01B $0.03B 0.36
2023-02-28 $0.01B $0.03B 0.35
2022-11-30 $0.02B $0.02B 0.83
2022-08-31 $0.02B $0.02B 0.85
2022-05-31 $0.03B $0.04B 0.62
2022-02-28 $0.03B $0.05B 0.58
2021-11-30 $0.02B $0.04B 0.46
2021-08-31 $0.02B $0.04B 0.41
2021-05-31 $0.01B $0.04B 0.15
2021-02-28 $0.01B $0.03B 0.20
2020-11-30 $0.01B $0.03B 0.20
2020-08-31 $0.01B $0.03B 0.20
2020-05-31 $0.01B $0.03B 0.20
2020-02-29 $0.01B $0.03B 0.21
2019-11-30 $0.01B $0.03B 0.26
2019-08-31 $0.01B $0.03B 0.26
2019-05-31 $0.01B $0.03B 0.25
2019-02-28 $0.00B $0.03B 0.17
2018-11-30 $0.01B $0.00B 8.78
2018-08-31 $0.01B $0.00B 26.45
2018-05-31 $0.01B $0.00B 16.06
2018-02-28 $0.01B $0.00B 13.36
2017-11-30 $0.01B $-0.00B -2.13
2017-08-31 $0.01B $-0.00B -2.29
2017-05-31 $0.01B $-0.01B -2.19
2017-03-31 $0.00B $0.00B 0.17
2017-02-28 $0.00B 0.00
2016-12-31 $0.00B 0.00
2016-11-30 $0.00B 0.00
2016-09-30 $0.00B $0.00B 0.13
2016-06-30 $0.00B $0.00B 0.43
2016-05-31 $0.00B 0.00
2016-03-31 $0.00B $0.00B 1.31
2015-12-31 $0.00B 0.00
2015-09-30 $0.00B $0.00B 1.14
2015-06-30 $0.00B $0.00B -1.65
2015-03-31 $0.00B $0.00B -1.40
2014-12-31 $0.00B 0.00
2014-09-30 $0.00B $-0.00B -1.23
2014-06-30 $0.00B $-0.00B -1.18
2014-03-31 $0.00B $-0.00B -1.32
2013-12-31 $0.00B 0.00
2013-09-30 $0.00B $-0.00B -1.43
2013-06-30 $0.00B $-0.00B -1.02
2013-03-31 $0.00B $-0.00B -1.05
2012-12-31 $0.00B $-0.00B -1.04
2012-09-30 $0.00B $-0.00B -1.53
2012-08-31 $0.00B 0.00
2012-06-30 $0.00B $0.00B -1.68
2012-03-31 $0.00B $-0.00B -1.12
2012-02-29 $0.00B 0.00
2011-12-31 $0.00B $-0.00B -1.01
2011-11-30 $0.00B 0.00
2011-09-30 $0.00B 0.00
2011-08-31 $0.00B $0.00B 0.00
2011-06-30 $0.00B 0.00
2011-05-31 $0.00B $0.00B 0.00
2011-03-31 $0.00B 0.00
2011-02-28 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.011B $0.013B
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $18.162B 10.99
Quest Diagnostics (DGX) United States $16.508B 17.06
DaVita (DVA) United States $12.078B 15.00
Encompass Health (EHC) United States $8.774B 22.46
Chemed (CHE) United States $8.268B 25.63
Elanco Animal Health (ELAN) United States $6.548B 16.99
Option Care Health (OPCH) United States $5.428B 20.55
RadNet (RDNT) United States $4.814B 100.25
Amedisys (AMED) United States $3.194B 22.62
Astrana Health (ASTH) United States $2.853B 38.60
Addus HomeCare (ADUS) United States $2.223B 28.77
LifeStance Health (LFST) United States $2.164B 0.00
U.S Physical Therapy (USPH) United States $1.487B 39.79
Pennant (PNTG) United States $0.823B 43.48
Aveanna Healthcare Holdings (AVAH) United States $0.708B 0.00
Atai Life Sciences (ATAI) Germany $0.275B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.027B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.020B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00